Medical intelligent low-temperature rapid hemostatic forceps

By combining medical intelligent low-temperature rapid hemostatic forceps with low-temperature plasma and intelligent control system, the shortcomings of traditional hemostasis methods are solved, and a rapid and safe hemostasis effect is achieved, which is suitable for different treatment needs.

CN120605087APending Publication Date: 2025-09-09YIZHENG PEOPLES HOSPITAL
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
CN202510636982.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-18
Publication Date
2025-09-09

AI Technical Summary

Technical Problem

Existing hemostasis methods have shortcomings in terms of speed, accuracy and safety, especially traditional compression hemostasis has low efficiency, electrocoagulation hemostasis has the risk of thermal damage, the operation is complicated and is not suitable for emergency or minimally invasive surgery.

Method used

It uses medical intelligent low-temperature rapid hemostatic forceps, combined with low-temperature plasma technology and intelligent control system, to achieve rapid and accurate hemostasis through replaceable electrodes and real-time temperature monitoring.

Benefits of technology

It achieves rapid hemostasis, reduces operation time and patient bleeding volume, reduces the risk of damage to surrounding tissues, and improves the safety and controllability of the operation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120605087A_ABST
    Figure CN120605087A_ABST
Patent Text Reader

Abstract

The invention discloses a pair of medical intelligent low-temperature rapid hemostatic forceps which comprises a forceps body, electrodes, a cooling module and a control box, rapid hemostasis is achieved through a low-temperature plasma technology, the electrodes generate low-temperature plasmas through current conduction, pathological tissues are rapidly decomposed, and bleeding is stopped. The cooling module and the electrodes cooperate to adjust the temperature of the treatment area in real time, and damage to normal tissue caused by overheating is avoided. The electrodes can be replaced, different treatment requirements are met, and a more flexible operation mode is provided. The method has the main beneficial effects that the hemostasis efficiency is remarkably improved, the treatment time and the intraoperative bleeding amount are reduced through a low-temperature plasma technology, the safety is better, the possible damage to normal tissues in a traditional method is avoided, the operation is convenient and fast, the treatment process is controlled in real time, and the method is widely suitable for hemostasis requirements in various medical operations.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of hemostatic forceps, in particular to a medical intelligent low-temperature rapid hemostatic forceps. Background Art

[0002] In modern medical treatment, especially in hemostasis treatment, rapid and effective hemostasis methods play a vital role in various surgeries. Traditional hemostasis methods mainly include compression hemostasis, electrocoagulation hemostasis, chemical hemostasis, etc. Although these methods can achieve certain hemostasis effects, each of them has some obvious shortcomings. The existing technologies mainly include the following methods: Compression hemostasis is the most common and simple method, typically using surgical instruments or direct manual pressure to stop bleeding. This method is effective for small wounds but is less effective for larger or complex wounds. The procedure also takes a long time, potentially increasing intraoperative bleeding. Compression hemostasis is time-consuming and can easily prolong surgery. It may not completely stop bleeding, especially in deep or vascularized areas, where its effectiveness is limited.

[0003] Electrocoagulation is a commonly used hemostatic technique that uses high-frequency current through electrodes to act on the bleeding site, generating high temperatures to stop bleeding. This method can quickly coagulate blood vessels and stop bleeding. Although electrocoagulation is effective, temperature control is difficult and can easily cause thermal damage to surrounding tissues, even scalding or deep burns. This can affect the surgical outcome, especially if performed improperly. In addition, electrocoagulation equipment is typically large, has poor operational flexibility, and is not suitable for all types of surgery.

[0004] Although existing technologies have made certain progress in different fields, there are still many shortcomings in terms of rapid, accurate and safe hemostasis treatment: Low healing efficiency: Existing hemostasis technology is inefficient during emergency treatment, especially for hemostasis of large areas or complex parts, which often takes a long time, increasing the patient's pain and intraoperative bleeding.

[0005] Damage to normal tissue: Traditional hemostasis methods, especially electrocoagulation and laser hemostasis, often cause overheating damage to surrounding healthy tissues, increasing the risk of postoperative complications.

[0006] High operational complexity: Traditional hemostasis methods, such as compression hemostasis and electrocoagulation hemostasis, require a lot of time and experience during the operation process. They are not suitable for emergency or minimally invasive surgery and may lead to untimely or inefficient treatment.

[0007] Poor safety: Existing chemical hemostasis methods carry the risk of drug reactions, while electrocoagulation and laser hemostasis carry the risk of overheating damage, and the protection of tissues during treatment is relatively limited.

[0008] In view of this, research and improvement are carried out on the existing problems, and a medical intelligent low-temperature rapid hemostatic forceps is provided to solve the current problems. The purpose is to achieve the purpose of solving problems and improving practical value through this technology. Summary of the Invention

[0009] The present invention aims to solve one of the technical problems existing in the prior art or related technologies.

[0010] To this end, the present invention relates to a medical intelligent low-temperature rapid hemostatic forceps, which combines low-temperature plasma technology with an intelligent control system and is mainly used for rapid and effective hemostasis in the medical field. The specific technical solution is as follows: A medical intelligent low-temperature rapid hemostatic forceps, characterized by comprising: a forceps body, electrodes, a cooling module and a control box.

[0011] The clamp body is made of medical-grade stainless steel, which is high-strength, heat-resistant, and corrosion-resistant, ensuring long-term stability and safety in medical environments. The clamp body is designed with a retractable jaw section, providing a convenient interface for operators.

[0012] The electrodes are used to generate low-temperature plasma. Made of a highly conductive alloy, they effectively conduct current and generate low-temperature plasma. They are designed to be replaceable to meet diverse treatment needs.

[0013] The cooling module consists of a low-temperature section and a heating section, which are used to adjust the temperature in real time during treatment, preventing damage to normal tissue from overheating and improving hemostasis. Through precise temperature regulation, the temperature of the treatment area is lowered, minimizing tissue damage and improving hemostasis efficiency.

[0014] The control box contains a microcontroller, display interface, power module, and cooling system. The microcontroller adjusts the low-temperature plasma generator's operating state according to set parameters, while sensors monitor the temperature and pressure in the treatment area in real time. The control box's design allows the operator to easily set treatment parameters and provides real-time feedback on temperature and pressure data during treatment, ensuring safe and accurate treatment.

[0015] In a preferred example, the present invention can be further configured as follows: the electrodes are replaceable structures, and electrodes of different shapes and sizes can be replaced according to different treatment needs.

[0016] The electrodes in this invention are detachable, allowing the operator to select electrodes of different shapes and sizes based on the size and morphology of the lesion. The electrode fixing interface is standardized to ensure that the stability and safety of the device are not affected during replacement.

[0017] Working effect: The replaceable design of the electrode enables the device to adapt to different treatment needs, ensuring the flexibility and diversity of the device and being suitable for the treatment of different types of lesions.

[0018] In a preferred example, the present invention can be further configured as follows: the control box further includes a touch screen or button interface for the operator to input treatment parameters and adjust parameters such as plasma intensity and treatment time in real time.

[0019] The control box is equipped with a touchscreen or push-button interface, allowing the operator to input desired treatment parameters, such as plasma intensity and treatment time. The microcontroller then adjusts the device's operating status in real time. The touchscreen interface is simple and intuitive, allowing the doctor to quickly operate the device even under high-pressure conditions.

[0020] Working effect: The interface simplifies the operation process, makes the use of the device more convenient, and ensures the accurate input and real-time adjustment of treatment parameters.

[0021] In a preferred example, the present invention can be further configured as follows: a sensor is embedded in the electrode surface, the sensor is a temperature sensor, a contact sensor or a pressure sensor, and the sensor is embedded in the electrode surface for real-time monitoring of the temperature, contact condition or clamping pressure of the treatment area.

[0022] Temperature sensors, contact sensors, or pressure sensors are embedded in the electrode surface. These sensors monitor the temperature, contact conditions, and clamping pressure of the treatment area in real time and feed this data back to the microcontroller. Based on this sensor feedback, the microcontroller automatically adjusts the output power of the low-temperature plasma generator.

[0023] Working effect: Real-time monitoring by sensors can ensure that the temperature and pressure during treatment are in the optimal state, thereby improving the treatment effect and preventing harm to the patient due to overheating or excessive clamping.

[0024] In a preferred example, the present invention can be further configured as follows: a cooling system for cooling the low-temperature plasma generator, the power module and the microcontroller is provided on the surface of the control box; the cooling system is a liquid cooling system or an air cooling system, which is used to dissipate the generated heat to the external environment through pipes or radiators; the power module is a rechargeable lithium battery with sufficient capacity to support the continuous operation of the equipment during long-term operation.

[0025] The cooling system in this invention incorporates a built-in liquid or air cooling system, which dissipates heat generated by the low-temperature plasma generator, power module, and microcontroller to the external environment via a radiator. The power module uses a rechargeable lithium battery with a high capacity, which can support long-term stable operation of the device.

[0026] Working effect: The cooling system ensures the stability of the device during long-term use, avoiding damage to the device or unstable treatment effect due to overheating; the lithium battery ensures that the device can support long-term and efficient work.

[0027] In a preferred example, the present invention can be further configured as follows: the clamp body is made of medical-grade stainless steel with good corrosion resistance, high temperature resistance and biocompatibility, and an insulating gasket is provided at the contact point between the electrode and the clamp body.

[0028] The clamp body is made of medical-grade stainless steel, offering excellent corrosion resistance, high temperature resistance, and biocompatibility, ensuring no adverse reactions with the human body during long-term use. An insulating gasket is installed at the contact point between the electrode and the clamp body to prevent electrical interference or electric shock between the electrode and the clamp body.

[0029] Working effect: By setting the insulating gasket, the electrical safety of the equipment can be ensured, unnecessary electrical accidents can be prevented, and the safety of patients and operators can be guaranteed.

[0030] In a preferred example, the present invention can be further configured as follows: the jaws are connected by a hinge, and the opening and closing angles of the jaws can be adjusted to meet the needs of different treatment parts. The locking teeth are arranged in a rack shape on the gripping part of the jaws for locking the jaws in a closed state, and the touch switch is turned on when the locking teeth are in contact.

[0031] The jaws are hinged to the jaws, allowing for adjustable opening and closing angles to meet the needs of different treatment areas. Rack-shaped locking lugs, located in the grip of the jaws, ensure stable closure during treatment and activate the low-temperature plasma generator by triggering a switch.

[0032] Working effect: The design ensures that the jaws are stable and efficient during operation, facilitating the doctor's operation while providing stable treatment effects.

[0033] The beneficial effects achieved by the present invention are: 1. This invention utilizes low-temperature plasma technology, generating low-temperature plasma through electrodes. This rapidly pulverizes organic molecules in diseased tissue and separates diseased cells, achieving rapid hemostasis in a fraction of the time. Compared to traditional hemostasis methods, this method offers significant speed advantages, effectively reducing surgical time and blood loss.

[0034] 2. This invention incorporates a cooling module to regulate the temperature of the treatment area in real time, preventing overheating and damage to surrounding healthy tissue. The application of low-temperature plasma allows precise targeting of the affected area, minimizing damage to normal tissue and improving surgical safety and effectiveness.

[0035] 3. In this invention, the intelligent control system allows operators to easily adjust parameters such as plasma intensity and treatment time through a touchscreen or button interface. Combined with real-time sensors monitoring temperature, pressure, and contact conditions, it ensures optimal operating conditions throughout the treatment process, significantly improving the controllability and safety of the procedure. Furthermore, the replaceable electrode design enhances the adaptability and flexibility of the device, adapting to the treatment needs of different lesions. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 This is a schematic diagram of the overall structure of an embodiment of the present invention; Figure 2 This is a schematic structural diagram of an electrode and a cooling module according to an embodiment of the present invention; Figure 3 This is a schematic structural diagram of a cooling module according to an embodiment of the present invention; Figure 4 For an embodiment of the present invention Figure 3 Schematic diagram of the structure at A; Figure 5 The figure is a schematic diagram of the structure of a touch switch according to an embodiment of the present invention.

[0037] Reference numerals: 100, clamp body; 110, connecting rod; 120, cable; 130, locking lug; 131, touch switch; 200, electrode; 210, tooth plate; 300, cooling module; 310, low temperature part; 320, heating part; 400. Control box. DETAILED DESCRIPTION

[0038] To make the purpose, technical solutions and advantages of the present invention more clear, the present invention is further described in detail below in conjunction with specific embodiments and with reference to the accompanying drawings. It should be noted that the embodiments of the present invention and the features therein can be combined with each other without conflict.

[0039] It is to be understood that these descriptions are illustrative only and are not intended to limit the scope of the invention.

[0040] The following is combined with Figure 1-Figure 5 Some embodiments of the present invention provide a medical intelligent low-temperature rapid hemostatic forceps.

[0041] Example 1: The medical intelligent low-temperature rapid hemostatic forceps comprises: a forceps body 100, an electrode 200, a cooling module 300 and a control box 400.

[0042] The forceps body 100 is made of medical-grade stainless steel, offering excellent corrosion resistance, high temperature resistance, and biocompatibility. Its surface is specially treated to enhance antibacterial properties, preventing infection during surgery. Ergonomically designed grips on both sides of the forceps ensure comfort during operation.

[0043] Electrode 200 is fixed to the tip of forceps 100 and transmits low-temperature plasma to the affected tissue via an electric current. The electrode is designed to be replaceable, allowing for selection of electrodes of varying shapes and sizes based on specific treatment needs. The electrode surface is constructed of highly conductive materials, such as tungsten alloy or copper alloy, ensuring efficient conduction and a long service life.

[0044] The cooling module 300 consists of a thermocouple structure, comprising a low-temperature portion 310 and a heating portion 320. The low-temperature portion 310 is embedded in the clamp body 100 and adhesively bonded to one side of the electrode 200, providing real-time temperature control on the electrode surface. The heating portion 320 dissipates heat to prevent the low-temperature plasma from overheating and damaging surrounding healthy tissue. The cooling module works in conjunction with the electrode to continuously control temperature during treatment.

[0045] The control box 400 includes a microcontroller, a display interface, a power module, and a cooling system. The microcontroller regulates the low-temperature plasma generator's operating state based on operator-defined parameters such as low-temperature plasma intensity, treatment time, and temperature. The control box allows parameter input via a touchscreen or button interface and displays device status in real time.

[0046] In this embodiment, the electrodes 200 are interchangeable, allowing for replacement of electrodes of varying shapes and sizes based on specific treatment needs. In practical applications, the removable design of the electrodes 200 allows the operator to quickly replace electrodes of varying shapes or sizes based on the specific location and size of the lesion or treatment needs. The electrodes are securely connected to the clamp body via slots or threaded connections, ensuring stability during operation. The electrodes can be made of highly conductive metal and feature a corrosion-resistant coating, ensuring resistance to wear and tear over extended use.

[0047] In this embodiment, the control box 400 further includes a touchscreen or button interface for the operator to input treatment parameters and adjust parameters such as plasma intensity and treatment time in real time. The control box 400 is equipped with a touchscreen interface, allowing the operator to easily set parameters such as plasma intensity and treatment time. The microcontroller adjusts the operating status of the low-temperature plasma generator in real time based on the input parameters. Furthermore, the control box's display provides real-time feedback on treatment progress and device status, ensuring comprehensive monitoring of the treatment process.

[0048] In this embodiment, a sensor is embedded and installed on the surface of the electrode 200. The sensor is a temperature sensor, a contact sensor or a pressure sensor, and the sensor is embedded and installed on the surface of the electrode 200 for real-time monitoring of the temperature, contact condition or clamping pressure of the treatment area. The surface of the electrode 200 is embedded with a temperature sensor, a contact sensor or a pressure sensor, which can monitor the temperature, contact condition or clamping pressure of the treatment area in real time. The temperature sensor is used to monitor the temperature of the area where the electrode surface contacts the tissue in real time to ensure that the temperature is controlled within a safe range. The contact sensor can detect the contact condition between the electrode and the tissue to avoid failure of the low-temperature plasma power due to poor contact. The pressure sensor is used to monitor the pressure of the jaw clamping to ensure that excessive pressure is not applied to the tissue during treatment to avoid tissue damage.

[0049] In this embodiment, the surface of the control box 400 is provided with a cooling system for cooling the low-temperature plasma generator, the power module and the microcontroller. The cooling system is a liquid cooling system or an air cooling system, which is used to dissipate the generated heat to the external environment through pipes or radiators. The power module is a rechargeable lithium battery with sufficient capacity to support the continuous operation of the equipment during long-term operation.

[0050] The cooling system, built into the control box 400, utilizes liquid or air cooling to effectively dissipate heat generated by the low-temperature plasma generator, power module, and microcontroller through a radiator or heat exchanger. The power module utilizes a high-capacity rechargeable lithium battery, providing stable power for extended periods of operation. A display monitors the battery charge in real time, reminding the operator to replace or recharge the battery promptly.

[0051] In this embodiment, the clamp body 100 is made of medical-grade stainless steel, which offers excellent corrosion resistance, high temperature resistance, and biocompatibility. An insulating gasket is provided at the contact point between the electrode 200 and the clamp body 100. The clamp body 100 is made of medical-grade stainless steel, which offers excellent corrosion resistance, high temperature resistance, and biocompatibility. An insulating gasket is provided at the contact point between the electrode 200 and the clamp body 100 to prevent the electrode from directly contacting the clamp body during use, potentially preventing electrical interference or damage to normal tissue.

[0052] In this embodiment, the jaws of the pliers body 100 are connected by a hinge, and the opening and closing angles of the jaws can be adjusted to meet the needs of different treatment parts. The locking teeth ears 130 are arranged in a rack-like shape on the gripping part of the pliers body 100 for locking the jaws of the pliers body 100 in a closed state, and the touch switch 131 is touched and turned on when the locking teeth ears 130 come into contact.

[0053] The jaws of the forceps 100 are hinged, allowing for adjustable opening and closing angles to accommodate different treatment areas. The gripping portion of the forceps is equipped with locking lugs 130, which, through a rack design, automatically lock the jaws when closed, ensuring stability during treatment. A trigger switch 131, when engaged by the locking lugs 130, activates the current, initiating low-temperature plasma treatment.

[0054] In this embodiment, the medical intelligent low-temperature rapid hemostatic forceps of the present invention are used to treat nosebleeds. The operator first sets the low-temperature plasma intensity to medium and the treatment time to 30 seconds through the control box 400. The operator clamps the patient's diseased tissue in the nasal cavity with the jaws. After starting the device, the low-temperature plasma generator begins to work, generating low-temperature plasma through the electrode 200 to quickly stop bleeding. During the treatment process, the sensor monitors the temperature of the treatment area in real time and adjusts the power of the plasma generator through the microcontroller to ensure that the temperature is within a safe range. The cooling module 300 continues to work to prevent overheating and damage to surrounding healthy tissue.

[0055] Example 2: This embodiment demonstrates the use of the present invention to stop bleeding after soft tissue tumor resection. During the operation, the operator sets the low-temperature plasma intensity to a higher value through the control box 400 and sets the treatment time to 60 seconds. The operator clamps the tissue at the tumor resection site, and the low-temperature plasma generated by the electrode 200 comes into contact with the diseased tissue to quickly stop bleeding. During the treatment, the temperature sensor and the pressure sensor work together to ensure that no excessive harm is caused to the patient. The cooling module 300 adjusts the temperature in real time to prevent tissue necrosis caused by excessive temperature. After the treatment is completed, the operator releases the lock, easily removes the hemostatic forceps, and performs a final inspection.

[0056] The working principle and use process of the present invention: Working principle: The medical intelligent low-temperature rapid hemostatic forceps of the present invention, combined with low-temperature plasma technology and an intelligent control system, are used to stop bleeding quickly and accurately. Its working principle is as follows: Low-Temperature Plasma Generation: The low-temperature plasma generator generates low-temperature plasma controlled by a microcontroller within control box 400. The microcontroller adjusts the plasma generator's operating intensity and duration based on treatment parameters input by the user. Electrodes 200 conduct current to generate low-temperature plasma on the affected tissue. Low-temperature plasma, with its high-energy ionization properties, rapidly pulverizes organic molecules in affected tissue and separates diseased cells, achieving rapid hemostasis.

[0057] Intelligent Control and Feedback: Sensors such as temperature, contact, or pressure sensors are embedded in the surface of electrode 200 to monitor the temperature, tissue contact, and clamping pressure of the treatment area in real time. If the temperature in the treatment area is too high or the clamping pressure is too high, the sensors will provide feedback to the microcontroller in the control box 400. Based on the sensor feedback, the microcontroller automatically adjusts the plasma intensity to ensure safety and effectiveness during treatment.

[0058] Cooling and Protection: While the low-temperature plasma is acting, the cooling module 300 rapidly reduces the temperature of the treatment area, preventing overheating and damage to surrounding healthy tissue. The thermocouple consists of a low-temperature portion 310 and a heating portion 320. Heat is dissipated through the surface of the heating portion 320, while the low-temperature portion 310 is used to control the temperature of the electrode 200. This cooling effect not only reduces pain but also improves hemostasis and prevents secondary damage caused by heat accumulation.

[0059] Manual Control and Locking: The grip of the pliers 100 is equipped with locking teeth 130, which the operator can manually adjust the opening and closing angle of the jaws. Through the rack design, the locking teeth 130 can automatically lock the jaws when closed, and simultaneously activate the touch switch 131, ensuring the stability of the jaws during operation, saving effort and facilitating operation.

[0060] Data Monitoring and Operation Interface: The control box 400 features a touchscreen or push-button interface, allowing users to input treatment parameters (such as plasma intensity and treatment time) as needed. The control box also displays real-time device status and treatment progress. The microcontroller controls various device functions based on the input parameters and provides status feedback to the operator via the display interface, ensuring controllable and monitorable treatment.

[0061] Usage process: Preparation: The operator removes the medical intelligent low-temperature rapid hemostatic forceps from the equipment box and inspects the device for proper function, ensuring all connections (power supply, cables, control box, etc.) are correct. Connect the electrode 200 to the forceps body 100, ensuring the electrode is securely fastened to the forceps head. Inspect and install the cooling module 300, ensuring it is securely fastened to the forceps body 100 to prevent loosening during operation.

[0062] Parameter setting: The operator turns on the device and enters the required parameters for treatment through the touch screen or button interface on the control box 400, including low-temperature plasma intensity, treatment time, temperature, etc. After the settings are completed, the operator confirms that all parameters are correct and prepares to start treatment.

[0063] During the treatment phase, the operator grasps the gripping portion of the forceps 100, closes the jaws, and adjusts the rack design of the locking lugs 130 to lock the jaws after clamping the vessel or blocking the block, ensuring a stable treatment area. The surface of the locking lugs 130 triggers the switch 131, activating current input to the electrodes 200. The jaws grasp the affected tissue requiring hemostasis, ensuring contact between the electrodes 200 and the tissue surface. The microcontroller in the control box 400 then controls the low-temperature plasma generator and electrodes 200, generating low-temperature plasma.

[0064] The sensor monitors the temperature and pressure between the surface of the electrode 200 and the blood vessel clamp in real time. If the temperature does not reach the optimal coagulation temperature or the clamping is improper, the microcontroller automatically adjusts the working intensity based on the feedback to ensure the safety of treatment.

[0065] The cooling module 300 works in conjunction with the electrode 200 to adjust the temperature in real time to avoid damage to healthy tissues while improving the hemostatic effect.

[0066] Ending Phase: When the treatment time expires, the microcontroller automatically stops the low-temperature plasma generator, and the treatment ends. The operator unlocks the clamp head and easily removes the hemostat. A final inspection of the treatment area is performed to ensure there is no abnormal bleeding or trauma.

[0067] Summarize: This invention ensures efficient, safe, and controllable treatment through precise control of low-temperature plasma and real-time feedback from an intelligent monitoring system. During treatment, the combination of low-temperature plasma generator operation, temperature control, manual operation, and automatic monitoring provides doctors with a convenient, safe, and efficient hemostasis solution.

[0068] Throughout this specification, terms such as "one embodiment," "some embodiments," and "specific embodiments" mean that the specific features, structures, materials, or characteristics described in conjunction with that embodiment or example are included in at least one embodiment or example of the present invention. In this specification, illustrative uses of these terms do not necessarily refer to the same embodiment or example. Furthermore, the specific features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.

[0069] Although the embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the invention, and that the scope of the invention is defined by the claims and their equivalents.

Claims

1. A medical intelligent low-temperature rapid hemostatic forceps, characterized in that: include: A clamp body (100), an electrode (200), a cooling module (300) and a control box (400); a connecting rod (110) is provided on the surface of the clamp body (100), and a cable (120) connected to the control box (400) is provided at the end of the connecting rod (110); the electrode (200) is fixed to the clamp head of the clamp body (100), and the cooling module (300) is embedded in the clamp head of the clamp body (100) and fixedly adhered to one side of the electrode (200); a tooth plate (210) is provided on the surface of the electrode (200); The gripping portion of the clamp body (100) is provided with a locking tooth ear (130), and a touch switch (131) for controlling the electrical connection between the cable (120) and the electrode (200) is embedded and installed on the surface of the locking tooth ear (130); the control box (400) includes a microcontroller and a display interface, and a low-temperature plasma generator and a power module are provided inside the control box (400), and the microcontroller is used to control the working state, intensity adjustment and operation feedback of the low-temperature plasma generator.

2. The medical intelligent low-temperature rapid hemostatic forceps according to claim 1, characterized in that: The electrode (200) is a replaceable structure, and electrodes of different shapes and sizes can be replaced according to different treatment requirements.

3. The medical intelligent low-temperature rapid hemostatic forceps according to claim 1, characterized in that: The control box (400) further comprises a touch screen or button interface for an operator to input treatment parameters and adjust parameters such as plasma intensity and treatment time in real time.

4. The medical intelligent low-temperature rapid hemostatic forceps according to claim 1, characterized in that: A sensor is embedded and installed on the surface of the electrode (200), and the sensor is a temperature sensor, a contact sensor or a pressure sensor, and the sensor is embedded and installed on the surface of the electrode (200) for real-time monitoring of the temperature, contact condition or clamping pressure of the treatment area.

5. The medical intelligent low-temperature rapid hemostatic forceps according to claim 1, characterized in that: The control box (400) is provided with a cooling system on its surface for cooling the low-temperature plasma generator, the power module and the microcontroller. The cooling system is a liquid cooling system or an air cooling system for dissipating the generated heat to the external environment through pipes or radiators. The power module is a rechargeable lithium battery with sufficient capacity to support the continuous operation of the device during long-term operation.

6. The medical intelligent low-temperature rapid hemostatic forceps according to claim 1, characterized in that: The clamp body (100) is made of medical-grade stainless steel, having good corrosion resistance, high temperature resistance and biocompatibility, and an insulating gasket is provided at the contact point between the electrode (200) and the clamp body (100).

7. The medical intelligent low-temperature rapid hemostatic forceps according to claim 1, characterized in that: The clamp body (100) and the clamp head are connected by a hinge, and the opening and closing angles of the jaws can be adjusted to meet the needs of different treatment parts. The locking teeth ears (130) are arranged in a rack shape on the gripping part of the clamp body (100) and are used to lock the clamp head of the clamp body (100) in a closed state, and the touch switch (131) is touched and turned on when the locking teeth ears (130) are in contact.

8. The medical intelligent low-temperature rapid hemostatic forceps according to claim 1, characterized in that: The low-temperature plasma generator adopts dielectric barrier discharge (DBD) technology to generate low-temperature plasma, which can accurately control the energy output of the plasma to avoid damage to normal tissues.

9. The medical intelligent low-temperature rapid hemostatic forceps according to claim 1, characterized in that: The cooling module (300) is a thermocouple structure and comprises a low-temperature portion (310) and a heating portion (320). The low-temperature portion (310) is embedded in the clamp head of the clamp body (100) and is bonded to one side of the electrode (200). A heat dissipation patch is provided on the surface of the heating portion (320). The low-temperature portion (310) is used to cool the surface of the electrode (200), thereby improving the hemostatic effect through the cooling effect.

Citation Information

Patent Citations

  • Bipolar clamp type cutting and melting cutter for throat

    CN107736936A

  • Probe and treatment device using probe

    CN110236670A

  • Plasma irradiation device, hand piece, and surgical operation device

    CN110573101A

  • Plasma irradiation apparatus and plasma irradiation method

    CN113940145A

  • Water outlet coagulation forceps

    CN115590611A